0406-9920-01Tablets 25 mg – round, biconvex, coral-reddish tofranil medication sugar-coated tablet, imprinted with M on one side and tofranil medication on the other side in tofranil medication of 30........................NDC 0406-9921-03Bottles of 100...................NDC 0406-9921-01Tablets tofranil medication mg – tofranil medication biconvex.

are started on antidepressant therapy should tofranil medication monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes tofranil medication behavior. tofranil medication and caregivers should be advised of the need for tofranil medication observation and communication with the tofranil medication Imipramine hydrochloride is not tofranil medication for tofranil medication tofranil medication pediatric patients tofranil medication WARNINGS: Clinical Worsening and Suicide Risk, PRECAUTIONS: INFORMATION FOR PATIENTS, and tofranil medication Pediatric Use).DRUG DESCRIPTIONINDICATIONSDepression – For the relief of symptoms tofranil medication depression. tofranil medication depression is more likely to be alleviated than other depressive states. tofranil medication to three weeks of treatment may be needed before optimal tofranil medication effects are evident.Childhood Enuresis – May tofranil medication useful as temporary tofranil medication therapy in reducing enuresis in children aged tofranil medication years and older, after possible organic causes tofranil medication been excluded by appropriate tests. In patients having daytime symptoms of frequency and tofranil medication examination should include voiding.

as compared to hospitalized patients tofranil medication will tofranil medication under close supervision. Dosage should tofranil medication initiated at a low level and increased.